Biointron Awarded 2025 Scientist.com Supplier Performance Recognition Award

Biointron, a specialized antibody contract research organization (CRO), has been awarded the 2025 Scientist.com Supplier Performance Recognition Award for outstanding performance in delivering drug discovery research services through Scientist.com’s global R&D sourcing platform.

Scientist.com is the market-leading digital marketplace for outsourced R&D, trusted by leading biopharmaceutical companies and research institutions worldwide. This annual recognition is granted to suppliers who demonstrate excellence across key performance indicators, including responsiveness to client requests, marketplace activity, and customer satisfaction.

Demonstrated Excellence in 2025 Performance  

Throughout 2025, Biointron demonstrated strong operational performance on the Scientist.com platform, with the most utilized services on Scientist.com in 2025 being antibody services, protein services, and DNA & RNA solutions.

Supporting Global Drug Discovery 

Biointron partners with researchers worldwide to accelerate drug discovery by providing dependable, high-quality antibody and molecular biology services. Through a combination of scientific expertise, streamlined workflows, and responsive project support, Biointron helps clients reduce risk, improve efficiency, and move programs forward faster.

Recognition from Scientist.com reflects Biointron’s continued focus on service quality, technical rigor, and meeting the evolving needs of the global research community.

About Biointron

Biointron is an antibody-focused contract research organization (CRO) providing integrated solutions to support drug discovery and early development programs. The company specializes in antibody discovery, antibody engineering, recombinant protein expression, and molecular biology services, delivering customized solutions tailored to each client’s scientific objectives.

With expertise spanning recombinant monoclonal antibody generation, affinity maturation, antibody characterization, protein production, and DNA & RNA services, Biointron supports biopharmaceutical companies, biotechnology firms, and research institutions worldwide. Biointron is committed to high scientific standards, rapid turnaround times, and transparent collaboration to help advance innovative therapies from concept to clinic. Contact us at info@biointron.com to learn more.